These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32856496)

  • 1. The Effect of Frequency of Technology Uploads on Glycemic Control in Adult Insulin Pump Users.
    Gannon S; O'Keeffe D; O'Sullivan E
    J Diabetes Sci Technol; 2021 Mar; 15(2):519-520. PubMed ID: 32856496
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of Carelink, an internet-based insulin pump monitoring system, on glycemic control in rural and urban children with type 1 diabetes mellitus.
    Corriveau EA; Durso PJ; Kaufman ED; Skipper BJ; Laskaratos LA; Heintzman KB
    Pediatr Diabetes; 2008 Aug; 9(4 Pt 2):360-6. PubMed ID: 18774996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-Time Continuous Glucose Monitoring Benefits Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes Irrespective of Insulin Delivery Modality: Subanalysis of the MILLENNIAL Study.
    Teoh IH; Prabhu J; Mubita W; Azmi S; Urwin A; Doughty I; Leelarathna L; Thabit H
    J Diabetes Sci Technol; 2022 Jan; 16(1):252-253. PubMed ID: 34632831
    [No Abstract]   [Full Text] [Related]  

  • 4. Continuous Glucose Monitoring in Patients With Type 1 Diabetes Taking Insulin Injections.
    Davidson MB
    JAMA; 2017 Jan; 317(4):363-364. PubMed ID: 28118435
    [No Abstract]   [Full Text] [Related]  

  • 5. Important determinants of diabetes control in insulin pump therapy in patients with type 1 diabetes mellitus.
    Deeb A; Abu-Awad S; Abood S; El-Abiary M; Al-Jubeh J; Yousef H; AbdelRahman L; Al Hajeri A; Mustafa H
    Diabetes Technol Ther; 2015 Mar; 17(3):166-70. PubMed ID: 25513744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin Pump Adherence Behaviors Do Not Correlate With Glycemic Variability Among Youth With Type 1 Diabetes (T1D).
    Paprocki E; Staggs V; Patton S; Clements M
    J Diabetes Sci Technol; 2019 Jan; 13(1):142-143. PubMed ID: 30317860
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of use of specific features of subcutaneous insulin infusion systems and their relationship to metabolic control in patients with type 1 diabetes.
    Quirós C; Patrascioiu I; Giménez M; Vinagre I; Vidal M; Jansà M; Conget I
    Endocrinol Nutr; 2014; 61(6):318-22. PubMed ID: 24533929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the basal/bolus ratio on continuous glucose monitoring parameters in patients with type 1 diabetes.
    González-Vidal T; Rivas-Otero D; Ramos-Ruiz G; Agüeria-Cabal P; Lambert C; Ares J; Delgado E; Menéndez-Torre E
    Diabetes Obes Metab; 2024 Aug; 26(8):3482-3485. PubMed ID: 38826106
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycemic Tracking Before and After Insulin Pump Initiation.
    Johnson A; Hill NE; Godsland I; Oliver NS
    J Diabetes Sci Technol; 2020 Sep; 14(5):970-971. PubMed ID: 32146846
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of the freestyle libre 2 flash glucose monitoring system on diabetes-self-management practices and glycemic parameters among patients with type 1 diabetes using insulin pump.
    Al Hayek AA; Robert AA; Al Dawish MA
    Diabetes Metab Syndr; 2021; 15(5):102265. PubMed ID: 34488057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 diabetes glycemic management: Insulin therapy, glucose monitoring, and automation.
    Perkins BA; Sherr JL; Mathieu C
    Science; 2021 Jul; 373(6554):522-527. PubMed ID: 34326234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upload and Review of Insulin Pump and Glucose Sensor Data by Adults with Type 1 Diabetes: A Clinic Audit.
    Kong YW; Venkatesh N; Paldus B; Lee MH; Zhu JJ; Sawyer M; Chakrabarti A; Uren C; MacIsaac RJ; Jenkins AJ; O'Neal DN
    Diabetes Technol Ther; 2022 Jul; 24(7):531-534. PubMed ID: 35167376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic Variability Is Associated with Frequency of Blood Glucose Testing and Bolus: Post Hoc Analysis Results from the ProAct Study.
    Pfützner A; Weissmann J; Mougiakakou S; Daskalaki E; Weis N; Ziegler R
    Diabetes Technol Ther; 2015 Jun; 17(6):392-7. PubMed ID: 25734860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How should we use the short-acting insulin analog Lys-Pro in external continuous subcutaneous pumps?].
    Guerci B; Jeandidier N; Lassmann-Vague V; Renard E; Hanaire-Broutin H
    Diabetes Metab; 2000 Dec; 26(6):513-9. PubMed ID: 11173725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Ambulatory Glucose Profile in Patients With Type 1 Diabetes Mellitus After Switching From Sensor-Augmented Insulin Pump Therapy to a Do-It-Yourself Artificial Pancreas System: A Retrospective Data Analysis of Real-World Data.
    Müller-Korbsch M; Frühwald L; Kietaibl A
    J Diabetes Sci Technol; 2022 Nov; 16(6):1577-1579. PubMed ID: 35915931
    [No Abstract]   [Full Text] [Related]  

  • 16. Objectively Measured Adherence in Adolescents With Type 1 Diabetes on Multiple Daily Injections and Insulin Pump Therapy.
    Westen SC; Warnick JL; Albanese-O'Neill A; Schatz DA; Haller MJ; Entessari M; Janicke DM
    J Pediatr Psychol; 2019 Jan; 44(1):21-31. PubMed ID: 30184209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ProAct study: new features of insulin pumps improve diabetes management and glycemic control in patients after transition of continuous subcutaneous insulin infusion systems.
    Ziegler R; Tubili C; Chico A; Guerci B; Lundberg E; Borchert M; Löffler A; Bloethner S; Weissmann J; Pfützner A
    Diabetes Technol Ther; 2013 Sep; 15(9):738-43. PubMed ID: 23931739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glucose sensors, insulin pumps and smart pens are growing together - A clinical update to modern diabetes technology].
    Gehr B
    MMW Fortschr Med; 2020 Dec; 162(21-22):69-75. PubMed ID: 33319293
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin Pump Combined with Flash Glucose Monitoring: A Therapeutic Option to Improve Glycemic Control in Severely Nonadherent Patients with Type 1 Diabetes.
    Halbron M; Bourron O; Andreelli F; Ciangura C; Jacqueminet S; Popelier M; Bosquet F; Rouanet S; Amouyal C; Hartemann A
    Diabetes Technol Ther; 2019 Jul; 21(7):409-412. PubMed ID: 31265349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers.
    Commissariat PV; Boyle CT; Miller KM; Mantravadi MG; DeSalvo DJ; Tamborlane WV; Van Name MA; Anderson BJ; DiMeglio LA; Laffel LM
    Diabetes Technol Ther; 2017 Jun; 19(6):363-369. PubMed ID: 28581817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.